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ABSTRACT
This study evaluated sunﬂower (Helianthus annu-
us) seed agar (SSA) for differentiation of Candida
dubliniensis from Candida albicans on the basis of
colony characteristics and chlamydospore
production. Simpliﬁed SSA without creatinine
and KH2PO4 was also used. On both media,
C. dubliniensis isolates (n = 25) developed rough
colonies and formed abundant chlamydospores
after incubation for 24–48 h at 28C, while
C. albicans isolates (n = 53) showed smooth col-
onies with no evidence of chlamydospore forma-
tion. Cryptococcus neoformans isolates (n = 10)
formed brown colonies on both media. Simpliﬁed
SSA offers a simple and inexpensive tool for
presumptive differentiation of C. dubliniensis from
C. albicans in clinical microbiology laboratories.
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Candida dubliniensis is a recently described oppor-
tunistic pathogen that shares some important
taxonomic characteristics with Candida albicans,
such as germ tube formation and chlamydospore
production. Although isolated ﬁrst from HIV-
infected patients with oral candidiasis [1,2], it has
now been shown to cause candidaemia and
invasive candidiasis among non-HIV-infected
immunocompromised patients [3–5]. Considering
the growing epidemiological importance of
C. dubliniensis, the development of a simple
method to differentiate it from C. albicans in
clinical microbiology laboratories will help pre-
vent misidentiﬁcation [6]. This communication
reports that sunﬂower (Helianthus annuus) seed
agar (SSA) can be used as a substitute for bird
seed ⁄niger (Guizotia abyssinica) seed agar in dis-
tinguishing C. dubliniensis from C. albicans.
SSA was prepared as described previously [7]
with the following composition ⁄L: 50 g pulver-
ised H. annuus seeds, 1 g glucose, 1 g KH2PO4, 1 g
creatinine and 15 g agar. Brieﬂy, the seeds were
pulverised in a domestic blender and boiled in
1 L of distilled water for 30 min. The seed extract
obtained was cooled and ﬁltered through several
layers of gauze and then the remaining ingredi-
ents were added. The pH was adjusted to 5.5 and
the volume was made up to 1 L. The medium was
autoclaved at 15 lb ⁄ in2 pressure for 15 min. Sim-
pliﬁed SSA was prepared similarly, but without
creatinine and KH2PO4.
Twenty-three local clinical isolates of C. dubli-
niensis originating from sputum (n = 11), vaginal
swabs (n = 5), and endotracheal secretions
(n = 4), and one each from a catheter tip, urine
and bronchoalveolar lavage, as well as two
reference strains (CD 36 and CBS 7987), were
studied in comparison with 50 clinical isolates
and three reference strains (ATCC 90029, ATCC
2091, ATCC 90028) of C. albicans. Ten isolates of
Cryptococcus neoformans, ﬁve each from environ-
mental and clinical sources, were also included.
All the C. albicans isolates were positive in the
germ tube test and produced chlamydospores on
corn meal–Tween-80 agar. The identity of the
clinical C. albicans and C. dubliniensis isolates was
also conﬁrmed by the Vitek 2 yeast identiﬁcation
system (bioMe´rieux, Marcy l’Etoile, France), and
by semi-nested PCR ampliﬁcation of rDNA using
species-speciﬁc primers corresponding to unique
sequences within the internally transcribed spacer
2 (ITS 2), followed by direct sequencing of ITS 2
[8].
All 25 isolates of C. dubliniensis grew as rough
colonies with hyphal fringes on SSA as well as on
simpliﬁed SSA media (Fig. 1), and formed abun-
dant chlamydospores after 24–48 h of incubation
at 28C (Fig. 2). In contrast, all C. albicans strains
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yielded smooth colonies, and there was no evi-
dence for formation of chlamydospores on either
medium. Since both types of SSA were found to
be equally efﬁcacious in differentiating C. dubli-
niensis from C. albicans, simpliﬁed SSA medium
may be used in clinical microbiological laborat-
ories in routine initial screening for C. dubliniensis
from clinical specimens. Presumptively identiﬁed
C. dubliniensis isolates should then be conﬁrmed
by determining their inability to assimilate
a-methyl-D-glucoside, trehalose and xylose in
commercial yeast identiﬁcation systems. Alternat-
ively, rapid molecular methods, such as
semi-nested PCR ampliﬁcation of rDNA, may be
performed to conﬁrm the identity of the C. dubli-
niensis isolates. In addition, all isolates of Crypt.
neoformans formed brown colonies on both types
of SSA, and the colour intensity was comparable
to that on bird seed agar.
In 1999, Staib and Morschhauser [9] reported
for the ﬁrst time that Staib G. abyssinica seed–
creatinine agar [10] may be used to differentiate
C. dubliniensis and C. albicans. While C. dublini-
ensis formed abundant chlamydospores and
rough colonies on this medium, C. albicans grew
as smooth colonies with no chlamydospore
formation. In retrospect, similar observations
with respect to some C. albicans strains were
made by Staib and co-workers in 1988 while they
were routinely using Staib agar for the detection
of Crypt. neoformans in AIDS patients [11]. How-
ever, at that time, such atypical strains were
considered to be variants of C. albicans, and no
further attempts were made to identify them
[12]. More recently, Al-Mosaid et al. [13] evalu-
ated the efﬁcacy of Staib agar and caffeic acid–
ferric citrate agar for discriminating between
C. dubliniensis and C. albicans, and conﬁrmed the
usefulness only of Staib agar for this purpose.
On this medium, all C. albicans isolates grew as
smooth, shiny colonies, whereas 97.7% of the
isolates of C. dubliniensis grew as rough colonies.
In contrast, this distinguishing feature was not
observed on caffeic acid–ferric citrate agar,
where 87.4% of C. albicans and 93.8% of
C. dubliniensis isolates yielded rough colonies.
The present observations on the efﬁcacy of
simpliﬁed SSA for differentiation of C. dubliniensis
from C. albicans are consistent with those obtained
by Staib and Morschhauser [9] and Al-Mosaid
et al. [13] on Staib agar.
Since SSA is known to impart brown pigmen-
tation to Crypt. neoformans colonies, it has been
used occasionally for the isolation and presump-
tive identiﬁcation of Crypt. neoformans from sa-
prophytic and clinical sources [7,14,15]. However,
its efﬁcacy as a differential medium for C. dubli-
niensis and C. albicans has not been reported
previously. SSA may have underlying mecha-
nisms similar to bird seed agar for inducing
colonial roughness and chlamydospores in
C. dubliniensis and brown pigmentation in Crypt.
neoformans. The present observation that elimin-
ation of creatinine and KH2PO4 from SSA does
not affect adversely the development of brown
Fig. 1. Simpliﬁed sunﬂower seed agar showing rough and
fringed colonies of Candida dubliniensis (cd), smooth col-
onies of Candida albicans (ca) and brown colonies of
Cryptococcus neoformans (cn) after incubation for 48 h at
28C.
Fig. 2. Slide culture on simpliﬁed sunﬂower seed agar
showing chlamydospores of Candida dubliniensis, strain
848 ⁄ 02 (magniﬁcation, · 400).
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pigmentation in Crypt. neoformans is consistent
with previous studies using bird seed agar
[16,17]. An extended evaluation of simpliﬁed
SSA medium, including additional isolates of
C. dubliniensis, C. albicans and Crypt. neoformans,
is currently in progress.
In conclusion, simpliﬁed SSA offers a simple
and inexpensive alternative medium for differen-
tiation of C. dubliniensis from C. albicans. Exclusion
of KH2PO4 and creatinine from the medium does
not affect the ability of C. dubliniensis to form
rough colonies or chlamydospores, nor does it
appear to affect melanisation of Crypt. neoformans.
The ready availability of the ingredients and the
low cost of production make this an ideal medium
for large-scale epidemiological studies, partic-
ularly in HIV-infected patients, where C. albicans,
C. dubliniensis and Crypt. neoformans could occur
concomitantly.
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